Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities

Documenti analoghi

• A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia
  di: Elisa Lenti, et al.
  Pubblicazione: (2025)
• Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
  di: Gian Matteo Rigolin, et al.
  Pubblicazione: (2024)
• Long‐term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab
  di: Arnon P. Kater, et al.
  Pubblicazione: (2024)
• Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population‐based study in the Netherlands, 1996–2020
  di: Lina van der Straten, et al.
  Pubblicazione: (2024)
• Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse‐like cells via an RNA‐dependent mechanism
  di: Nathan Dubois, et al.
  Pubblicazione: (2025)